This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Deutsche Diabetes-Forschungsgesellschaft E.v.—trager Des Deutschen Diabetes-Zentrums Dusseldorf, Eberhard Karls Universitat Tubingen Medizinische F Akultat, Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 5 
1 out of 94 
Years Active: 2017
Title: Innovations by Wolfgang Rathmann in Diabetes Research
Introduction
Wolfgang Rathmann is a notable inventor based in Essen, Germany. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes. His work has the potential to improve early detection and prevention strategies for this prevalent condition.
Latest Patents
Wolfgang Rathmann holds a patent related to biomarkers for type 2 diabetes. The invention outlines a method for identifying a predisposition to develop type 2 diabetes mellitus by assessing specific metabolites in a subject's sample. The method involves evaluating the amounts of metabolites from two distinct groups, where changes in their levels can indicate a predisposition to the disease. Additionally, the patent includes methods for identifying compounds that may prevent type 2 diabetes and selecting appropriate therapies.
Career Highlights
Throughout his career, Rathmann has worked with esteemed organizations such as Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt and Deutsche Diabetes-Forschungsgesellschaft e.V. - Träger des Deutschen Diabetes-Zentrums Düsseldorf. His experience in these institutions has allowed him to collaborate with leading experts in the field.
Collaborations
Wolfgang Rathmann has collaborated with notable colleagues, including Christian Herder and Thomas Illig. These partnerships have contributed to advancing research in diabetes and enhancing the understanding of its underlying mechanisms.
Conclusion
Wolfgang Rathmann's innovative work in identifying biomarkers for type 2 diabetes represents a significant advancement in medical research. His contributions have the potential to lead to improved prevention and treatment strategies for this widespread health issue.